Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,247,000 | 1,808,000 | 1,520,000 | 1,878,000 | 1,036,000 |
| Marketable Securities | 19,979,000 | 18,085,000 | 10,432,000 | 10,673,000 | 7,579,000 |
| Receivables | 9,103,000 | 9,367,000 | 8,636,000 | 5,785,000 | 4,798,000 |
| Inventories | 5,478,000 | 6,660,000 | 5,699,000 | 2,678,000 | 2,485,000 |
| Other current assets | 7,169,000 | 835,000 | 1,632,000 | 1,970,000 | 1,896,000 |
| TOTAL | $46,835,000 | $39,088,000 | $30,677,000 | $24,781,000 | $19,212,000 |
| Non-Current Assets | |||||
| PPE Net | 16,233,000 | 18,385,000 | 18,156,000 | 10,712,000 | 9,783,000 |
| Investments And Advances | 2,497,000 | 3,873,000 | 6,142,000 | 5,161,000 | 5,724,000 |
| Intangibles | 47,229,000 | 57,007,000 | 57,856,000 | 2,121,000 | 1,689,000 |
| Other Non-Current Assets | 4,176,000 | 4,725,000 | 3,944,000 | 3,581,000 | 2,745,000 |
| TOTAL | $70,135,000 | $83,990,000 | $86,098,000 | $21,575,000 | $19,941,000 |
| Total Assets | $116,970,000 | $123,078,000 | $116,775,000 | $46,356,000 | $39,153,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,589,000 | 11,266,000 | 8,818,000 | 8,669,000 | 6,263,000 |
| Accounts payable and accrued liabilities | 2,073,000 | 2,672,000 | 2,587,000 | 1,620,000 | 1,411,000 |
| Accrued Expenses | 1,602,000 | 1,939,000 | 1,740,000 | 1,084,000 | 1,026,000 |
| Other current liabilities | 6,521,000 | 7,200,000 | 5,850,000 | 3,448,000 | 2,866,000 |
| TOTAL | $28,402,000 | $26,458,000 | $23,909,000 | $18,555,000 | $13,729,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,347,000 | 7,279,000 | 5,755,000 | 3,140,000 | 2,609,000 |
| Other Non-Current Liabilities | 6,750,000 | 9,037,000 | 8,722,000 | 4,347,000 | 4,124,000 |
| TOTAL | $22,804,000 | $28,342,000 | $27,489,000 | $7,851,000 | $7,131,000 |
| Total Liabilities | $51,206,000 | $54,800,000 | $51,398,000 | $26,406,000 | $20,860,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,357,944 | 7,458,874 | 7,625,056 | 6,158,348 | 6,265,231 |
| Common Shares | 439,000 | 438,000 | 435,000 | 341,000 | 340,000 |
| Retained earnings | 37,608,000 | 35,492,000 | 29,382,000 | 30,243,000 | 24,430,000 |
| Other shareholders' equity | -275,000 | 1,242,000 | -1,484,000 | -3,661,000 | -4,399,000 |
| TOTAL | $65,764,000 | $68,278,000 | $65,377,000 | $19,950,000 | $18,293,000 |
| Total Liabilities And Equity | $116,970,000 | $123,078,000 | $116,775,000 | $46,356,000 | $39,153,000 |